Magnesium Augmentation During Reperfusion for the Reduction of Postischaemic Myocardial Damage

  • A. H. Brown
  • J. Kitchen
Conference paper


The surgical benefits of the dry immobile heart provided by ischaemia are offset by ischaemic damage. Adequate cooling and cardioplegia have minimised this damage but during reperfusion it is manifested and worsened [1, 2]. At this stage, however, the surgeon has regained his control of the extracellular environment of the heart and can either restore or destroy the partially damaged cells.


Cardiopulmonary Bypass Aortic Root Intraventricular Pressure Additional Magnesium Nuclear Magnetic Resonanee 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cerra FB, Lajos TZ, Montes M, Siegel JH (1975) Hemorrhagic infarction: a reperfusion injury following prolonged myocardial ischaemic anoxia. Surgery 78: 95–104PubMedGoogle Scholar
  2. 2.
    Schaper J, Hehrlein F, Schleper M, Theidemann KU (1977) Ultrastructural alterations during ischemia and reperfusion in human hearts during cardiac surgery. J Mol Cell Cardiol 9: 175–189PubMedCrossRefGoogle Scholar
  3. 3.
    Lazar HL, Foglia RP, Mangonaro AJ, Buckberg GD (1978) Detrimental effects of premature use of inotropic drugs to discontinue cardiopulmonary bypass. Surg Forum 29: 276–282PubMedGoogle Scholar
  4. 4.
    Brown AH, Morritt GN, Hammo M (1982) Avoidance of reperfusion injury after cardioplegia. Thorax 37: 275–279PubMedCrossRefGoogle Scholar
  5. 5.
    Danforth WH, Naegle S, Bing RJ (1960) Effects of ischemia and reoxygenation on glycolytic reactions and adenosine triphosphate in heart muscle. Circ Res 8: 965–971PubMedGoogle Scholar
  6. 6.
    Follette DW, Steed DL, Foglia RP, Fey KH, Buckberg GD (1977) Reduction of post-is-chemic myocardial damage by maintaining arrest during initial reperfusion. Surg Forum 28: 281–283PubMedGoogle Scholar
  7. 7.
    Lazar HL, Buckberg GD, Manganaro AJ, Foglia RP, Becker H, Mulder GG, Maloney JV (1979) Reversal of ischemic damage with secondary blood cardioplegia. J Thorac Cardiovasc Surg 78: 688–697PubMedGoogle Scholar
  8. 8.
    Pernot AC, Ingwall JS, Menasche P, Grousset C, Bercot M, Mollet M, Piwnica A, Fossel ET (1981) Limitations of potassium cardioplegia during cardiac ischemic arrest: a phosphorus nuclear magnetic resonance study. Ann Thorac Surg 32: 536–545PubMedCrossRefGoogle Scholar
  9. 9.
    Furukawa Y, Chiba S (1981) Effects of magnesium on the isolated, blood perfused atrial and ventricular preparations of the dog heart. Spn Heart J 22: 239–246CrossRefGoogle Scholar
  10. 10.
    Shine KI (1979) Myocardial effects of magnesium. Am J Physiol 237: 413–23Google Scholar
  11. 11.
    Kerrick WGL, Donaldson SKB (1972) Effects of magnesium on submaximal calcium activated tension in skinned fibres of frog skeletal muscle. Biochem Biophys Acta 272: 117–124Google Scholar
  12. 12.
    Wacker WEC, Parisi AF (1968) Magnesium metabolism. N Engl J Med 278: 712PubMedCrossRefGoogle Scholar
  13. 13.
    Shen AC, Jennings RB (1972) Myocardial calcium and magnesium in acute ischemic injury. Am J Pathol 67: 417PubMedGoogle Scholar
  14. 14.
    Hearse DJ, Stewart DA, Braimbridge MV (1978) Myocardial protection during ischemic cardiac arrest; the importance of magnesium in cardioplegic infusates. J Thorac Cardiovasc Surg 75: 877–885PubMedGoogle Scholar
  15. 15.
    Kalmar P, Bleese N, Doring V, Gerckrn G, Kirsch U, Lierse W, Pokar H, Polonius MJ, Rodewald G (1975) Induced ischemic cardiac arrest: clinical and experimental results with magnesium aspartate procaine solution (cardioplegin). J Thorac Cardiovasc Surg 16: 470–8Google Scholar
  16. 16.
    Janke J, Fleckenstein A, Hein B, Leder O, Sigel H (1975) Prevention of myocardial calcium overload and necrotisation by magnesium and potassium salts or acidosis. Recent Adv Stud Card Struct Metab 6: 33–40Google Scholar
  17. 17.
    Poliment PI, Page E (1973) Magnesium in heart muscle. Circ Res 33: 367–374Google Scholar
  18. 18.
    Holden MP, Ionescu MI, Wooler GH (1972) Magnesium in patients undergoing open- heart surgery. Thorax 27: 212–219PubMedCrossRefGoogle Scholar
  19. 19.
    Raab W, Bajusz E, Kimura H, Herrlich HS (1968) Isolation stress, myocardial electrolytes and epinephrine in rats. Proc Soc Exp Biol Med 127: 142–14PubMedGoogle Scholar
  20. 20.
    Replogle RL, Levy M, DeWall Ra, Lillehei RC (1962) Catecholamines and serotonin response to cardiopulmonary bypass. J Thorac Cardiovasc Surg 44: 638–648PubMedGoogle Scholar
  21. 21.
    Tan C, Glisson SN, El-Etr AA, Ramakrishnaiah KB (1976) Levels of circulating norepinephrine and epinephrine before during and after cardiopulmonary bypass in man. J Thorac Cardiovasc Surg 71: 928–31PubMedGoogle Scholar
  22. 22.
    Raab CO (1969) Myocardial electrolyte derangement; crucial feature of pluricausal so- called coronary disease. Ann NY Acad Sci 147: 627–86PubMedCrossRefGoogle Scholar
  23. 23.
    Potter LT, Axelrod J (1963) Properties of norepinephrine storage particles of the rat heart. J Pharmacol Exp Ther 142: 299–305PubMedGoogle Scholar
  24. 24.
    Holden MP (1982) The value of magnesium therapy during open heart surgery. In: Nutrition and heart disease, ch 15. N.A.I.T.O. S.P. Medical and Scientific, New YorkGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • A. H. Brown
  • J. Kitchen

There are no affiliations available

Personalised recommendations